P240 Computerized Quantification of Tumor Infiltrating Lymphocyte (TIL) as a prognostic and predictive factor in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial. (April 2023) - Li, H.; Madabhushi, A.; Badve, S.; Cuzick, J.; Thorat, M.A.